Navigation Links
Bernstein honored with AACR Prevention Award
Date:11/28/2007

PHILADELPHIA Leslie Bernstein, Ph.D., a research expert on the effects of hormones and physical activity on cancer risk, late effects of cancer treatment, the impact of lifestyle on cancer prognosis, and quality of life after cancer, has been selected to receive the sixth annual American Association for Cancer Research (AACR)-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research.

The award is given annually to a scientist for seminal contributions to the field of cancer prevention research in basic, translational, clinical, epidemiological, or behavioral science.

Bernstein, professor and director of the Department of Cancer Etiology and dean for Faculty Development at City of Hope in Duarte, Calif., is being honored for her distinguished research career in cancer epidemiology and prevention, spanning nearly 25 years of discovery. She is internationally recognized as a preeminent researcher and scholar whose work has vast implications on the quality of life of cancer survivors.

Bernsteins early work examined the effects of exercise and body weight on the onset of puberty and hormonal patterns during adolescence. This research challenged the paradigm that epidemiologic risk factors for breast cancer were largely unmodifiable; demonstrated that physical activity can directly decrease breast cancer risk; and laid the foundation for subsequent epidemiologic studies and clinical trials focused on understanding the joint contributions of physical activity, weight and associated biologic mechanisms to the etiology of breast cancer. This area is now a primary international focus of cancer prevention and control research.

In later research, Bernstein identified ethnicity-related variations and determinants of poor prognosis in breast cancer patients. Bernstein is also a pioneer in the development and use of epidemiologic methods for evaluating the long-term side effects of cancer treatment in cancer survivors. Using a multicenter population-based setting she substantiated the association between tamoxifen use and risk of subsequent endometrial cancer in women and demonstrated for the first time that this association is potentially restricted to women who had previously used unopposed estrogen therapy or who were obese at the time of their breast cancer diagnosis. Recently, in a large HMO-based study of risk of stroke in relation to breast cancer therapies, she demonstrated the absence of an association between tamoxifen and stroke risk but an increased stroke risk following chemotherapy.

Past winners of AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention include Stephen Hecht, Ph.D., of The Cancer Center at the University of Minnesota, in 2006; Scott M. Lippman, M.D., of The University of Texas M. D. Anderson Cancer Center, in 2005; David S. Alberts, M.D., of the Arizona Cancer Center, in 2004; Waun Ki Hong, M.D., also of the M. D. Anderson Cancer Center, in 2003; and Michael B. Sporn, M.D., of the Dartmouth Medical School, in 2002.

Bernstein received her B.A. in Mathematics, M.S. in Gerontology, and Ph.D. in Biometry from the University of Southern California. She rose through the academic ranks of USC, culminating with her current positions of Professor of Preventive Medicine and the first AFLAC, Incorporated Chair in Cancer Research. Bernstein was named Professor Emeritus of USC following her retirement there in 2007.

Bernstein has received numerous honors and awards for her scientific accomplishments, including the American Society for Preventive Oncology Distinguished Achievement Award, the USC Presidential Medallion (the Universitys highest honor), and the Keck School of Medicine Stevely Hoffman Achievement Award. Her distinguished lectureships include the Cutter Lectureship at Harvard University, the Meadow Brook Lecture at Wayne State and Oakland Universities, and the Sloan Memorial Lecture at Boston University. Bernstein has authored or co-authored more than 400 scientific papers and publications.

An active member of AACR since 1995, Bernstein has served in various capacities, including as an Editorial Board member of Cancer Epidemiology, Biomarkers and Prevention, as a participant in Women in Cancer Research activities, and as a member of several committees.

Bernstein will give an award lecture entitled, Breast Cancer Prevention: Learning from the Past, Mentoring the Future, on Thursday, December 6, 2007, at the Sixth Annual AACR International Conference on Frontiers in Cancer Prevention Research. This foremost meeting on cancer prevention research will be held December 5-8, 2007 at the Philadelphia Marriott Downtown in Philadelphia.

The AACR is pleased to co-sponsor this award with the Prevent Cancer Foundation. The Foundation is a national, non-profit health foundation with a single mission: the prevention and early detection of cancer through scientific research and education.


'/>"/>

Contact: Jennifer Ryan
jennifer.ryan@aacr.org
267-646-0554
American Association for Cancer Research  
Source:Eurekalert

Related medicine news :

1. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
2. Vida Health Communications, Inc. to Be Honored as Tibbetts Award Winner
3. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
4. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. PureCart Systems of Green Bay, Wis., is an Honored Recipient of an iParenting Media Award
8. Concentra Honored With Silver Health at Work(SM) Award by ComPsych(R) Corp.
9. Terrell Herring Honored by Big Brothers Big Sisters
10. The Legendary Sir Roger Moore to be Honored at The Thalians 52nd Anniversary Gala On October 21, 2007 at the Beverly Hilton Hotel to Benefit The Thalians Mental Health Center at Cedars Sinai
11. LA breast cancer activist honored with Survivor Circle Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bernstein honored with AACR Prevention Award
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company is ... As a means of expanding capabilities Flottman has added a G&K Vijuk ... code professional inserts (PIs) and patient package inserts (PPIs) that will marry with ...
(Date:12/9/2016)... ... 2016 , ... Mediaplanet today announces distribution of the latest edition of “Transplants,” ... up as an organ donor for the 123,000 people in the United States who ... save up to 8 saves through organ donation and enhance many others through tissue ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest Healthcare ... owned by an affiliate of Seavest, has won a prestigious national healthcare real ... County ambulatory care center (ACC) was named “Best New Development, MOBs and Other ...
(Date:12/8/2016)... ... ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced today the launch ... world headquarters of Omni La Costa Resort & Spa in San Diego. , Chopra ... personal development, a healthy lifestyle, or mental and physical healing. The week-long wellness program ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: